Virtu Financial’s Lipella Pharmaceuticals LIPO Stock Holding History

Virtu Financial’s Portfolio LIPO Stock Details LIPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,310	Closed	-$41K	–	1729
2024 Q4	$41K	Buy	+13,310	New	+$40.4K	﹤0.01%	1187

Other funds holding LIPO

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's LIPO Position: Q1 2025 in Review

Virtu Financial sold out of Lipella Pharmaceuticals (LIPO) in Q1 2025, closing a stake of 13,310 shares — an estimated $41K sold.

Virtu Financial first reported a position in LIPO in Q4 2024 and held it in 1 quarter. The position peaked at $41K in Q4 2024. 3 funds tracked by Wall St. Rank hold LIPO as of Q1 2025.

Virtu Financial reported no remaining Lipella Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Virtu Financial sold 13,310 Lipella Pharmaceuticals shares in Q1 2025, an estimated $41K.
Virtu Financial first reported a position in Lipella Pharmaceuticals in Q4 2024 and held it in 1 quarter.
Virtu Financial's Lipella Pharmaceuticals position peaked at $41K in Q4 2024.
3 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.